Mochida Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mochida Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Kaken Pharmaceutical Co Ltd
sales of 98.43 billion Japanese Yen [US$872.09 million]
of which 98%
Nippon Shinyaku Co Ltd
(101.45 billion Japanese Yen [US$898.83 million]
of which 86%
was Pharmaceutical Products), and
KYORIN Holdings, Incorporation
(110.64 billion Japanese Yen [US$980.27 million]
of which 95%
was Pharmaceutical Business).
Mochida Pharmaceutical Company Limited reported sales of ¥106.76 billion (US$945.90 million)
March of 2018.
increase of 9.7%
versus 2017, when the company's sales were ¥97.35 billion.
This was the third consecutive year of growth at Mochida Pharmaceutical Company Limited.